Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 151,600 shares at $68.21 ($10.3M) on 2019-03-28, disclosed to the SEC on 2019-04-01.
Open-market sale of $10.3M GHDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,000 | $0 | 0.0% |
| 2 | $68.21 | 14,620 | $997K | 9.7% |
| 3 | $68.21 | 14,620 | $997K | 9.7% |
| 4 | $68.97 | 10,272 | $708K | 6.9% |
| 5 | $68.97 | 10,272 | $708K | 6.9% |
| 6 | $69.67 | 108 |
| $8K |
| 0.1% |
| 7 | $69.67 | 108 | $8K | 0.1% |
| 8 | $69.03 | 14,372 | $992K | 9.7% |
| 9 | $69.03 | 14,372 | $992K | 9.7% |
| 10 | $69.84 | 10,528 | $735K | 7.2% |
| 11 | $69.84 | 10,528 | $735K | 7.2% |
| 12 | $70.49 | 100 | $7K | 0.1% |
| 13 | $66.94 | 10,521 | $704K | 6.9% |
| 14 | $66.94 | 10,521 | $704K | 6.9% |
| 15 | $68.05 | 11,279 | $767K | 7.5% |
| 16 | $68.05 | 11,279 | $768K | 7.5% |
| 17 | $69.12 | 2,100 | $145K | 1.4% |
| 18 | $69.12 | 2,100 | $145K | 1.4% |
| 19 | $69.80 | 800 | $56K | 0.5% |
| 20 | $69.80 | 800 | $56K | 0.5% |
| 21 | $70.95 | 300 | $21K | 0.2% |
| Total | $67.65 avg | 151,600 | $10.3M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |